Methylation-dependent transcriptional silencing of CACNA2D3 was shown to contribute to the metastatic phenotype of estrogen-receptor-positive primary breast cancer, again illustrating a protective nature of the gene [118]. This evidence concerns the gene CACNA2D3 and breast carcinoma.